Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Daiichi Sankyo: PharmaVitae Profile' returned 14 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Daiichi Sankyo Co., Ltd: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 59 Pfizer Inc Santen Pharmaceutical Co., Ltd. Daiichi Sankyo Co., Ltd: PharmaVitae Profile Daiichi Sankyo Co., Ltd: PharmaVitae Model   Datamonitor, Jan 2009 financial statements and pipeline data Daiichi Sankyo Co., Ltd: PharmaVitae Model Les Laboratoires Servier: PharmaVitae Profile   Datamonitor, Nov 2010, Pages: 76 extent of Biogaran’s growth SWOT analysis ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly update Company introduction Company sales Company Boehringer Ingelheim GmbH: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 73 SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly update Company introduction Menarini: PharmaVitae Profile   Datamonitor, June 2010, Pages: 48 an otherwise diverse therapeutic focus SWOT analysis ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly update Company introduction Company sales Amgen Inc.: PharmaVitae Profile   Datamonitor, June 2010, Pages: 105 by damaging clinical trial data in 2007—Aranesp sales decline significantly from 2006– SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae Eli Lilly & Co.: PharmaVitae Profile   Datamonitor, July 2010, Pages: 101 & Johnson Merck & Co., Inc. NICE Systems Ltd Novartis AG Novo Nordisk A/S Pfizer Inc Pivotal Corporation Eli Lilly & Co.: PharmaVitae Profile Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile   Datamonitor, June 2010, Pages: 64 portfolio Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Executive summary Quarterly update Company introduction Company sales Company financials Key products Takeda Pharmaceutical Co., Ltd: PharmaVitae Profile   Datamonitor, Oct 2010, Pages: 98 - Investigate the diverse strategies being employed by Japan's oldest and largest pharmaceutical player Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter Eisai Co., Ltd: PharmaVitae Profile   Datamonitor, Jan 2011, Pages: 76 Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter 2 Executive summary Key findings Prescription pharmaceutical sales and growth rate performance Product Profiles: Marketed Antibacterials - Increasing genericization and fragmentation shape a crowded market   Datamonitor, Nov 2011, Pages: 110 OVERVIEW Key marketed products MARKETED PRODUCT PROFILES Levaquin/Cravit/Tavanic (levofloxacin; Johnson & Johnson/Daiichi Sankyo/Sanofi) Drug profile Development overview SWOT Genzyme Corporation   Datamonitor, May 2011, Pages: 95 purchase agreement with Sekisui Chemical Phase III leukemia trial fails primary endpoint SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae Bristol-Myers Squibb Co.: PharmaVitae Profile   Datamonitor, March 2011, Pages: 84 an imminent wave of generic compeitition. - Assess what makes BMS a model biopharma company and why its newfound focus could lead to the industry's next megamerger ABOUT THIS PROFILE - PharmaVitae Explorer Astellas Pharma Inc.: PharmaVitae Profile   Datamonitor, Oct 2010, Pages: 95 and, going forward, for the Japanese drugmaker to become a leading player in the overactive bladder space. Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network